Evaluating the Impact of Increased Dispensing of Opioid Agonist Therapy Take-Home Doses on Treatment Retention and Opioid-Related Harm among Opioid Agonist Therapy Recipients: A Simulation Study

Modified opioid agonist therapy (OAT) guidelines that were initially introduced during the COVID-19 pandemic allow prescribers to increase the number of take-home doses to fulfill their need for physical distancing and prevent treatment discontinuation. It is crucial to evaluate the consequence of a...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Narjes Shojaati, Nathaniel D. Osgood
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	MDPI AG 2023-08-01
श्रृंखला:	Systems
विषय:	agent-based modelling opioid agonist therapy COVID-19-related public health order methadone buprenorphine/naloxone retention in opioid agonist therapy
ऑनलाइन पहुंच:	https://www.mdpi.com/2079-8954/11/8/391
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!